INTRODUCTION AND OBJECTIVES: INTRODUCTION: Stimulator of interferon genes (STING), a cytosolic sensor of cyclic dinucleotide (CDN; c-di-AMP and c-di-GMP) activates type I interferons (IFN I) and pro-inflammatory cytokines. Recombinant Bacillus-Calmette Guerin (BCG) overexpressing CDN (STING-agonist) remains unexplored in non-muscle invasive bladder cancer (NMIBC). We hypothesize that intravesical recombinant BCG is more efficacious than BCG for NMIBC. We constructed a novel STING-agonist-like recombinant BCG Pasteur and Tice strains (rBCG-disA-OE) carrying plasmids that harbors diadenylate cyclase (disA) gene to test this hypothesis.
METHODS: METHODS: WT and rBCG-disA-OE were tested for immunotherapeutic potential in WT and STING-deficient murine macrophages, to ascertain STING-dependent IFN I and proinflammatory cytokines activation. Similar experiments were conducted in RT4, J5637, and NBT2 cell lines. Fisher 344 rats intravesically received 4 doses of 1.5 mg/kg N methyl N nitrosurea (MNU) to induce NMIBC. Intravesical instillation of WT-and rBCGdisA-OE was administered weekly x 6. Histologic tumor grade, tumor involvement index, gene expression (q-PCR) as well as systemic immune responses (ELISA) were assessed. Growth and virulence of rBCG-disA-OE in BALB/c and SCID mice were tested using aerosol infection protocol.
RESULTS: RESULTS: rBCG-disA-OE Pasteur and TICE strains overexpressing STING-agonist were potent inducers of IFN I in STING-dependent manner in murine macrophages. IFN I induction by rBCG-disA-OE increased TNF-a (P[0.01), IL-6 (P[0.04) and METHODS: AR expression was determined in 89 human urothelial BCa specimens by immunohistochemistry. A panel of BCa cell lines were treated with Cis, Enz, or a combination of both (EnzþCis). We determined the expression of AR, changes in apoptotic signaling, DNA damage, and analyzed effect on epithelial mesenchymal transformation markers.
RESULTS: AR expression was detected in 61.4% of tumors from male BCa patients. Enz inhibited proliferation of the ARþ bladder cancer cell lines TCCSUP (IC50 4.4 mM) and J82 (IC50 6.6mM) (Fig 1A  &B) . Enz at IC50 concentration induced apoptosis in TCCSUP cells (26%, p[0.0201) and J82 cells (15%, p[0.0386) (Fig.1C & 1D) . The combination of EnzþCis synergistically inhibited the proliferation of BCa cells even at low concentrations (5mM of Cis and 1.25 mM of Enz) (Fig 1A & 1B) . The combination of Enz and Cis at these low concentrations induced apoptosis in ARþ TCCSUP and J82 cells to a greater degree than individual agent alone at IC50 concentration (Fig.1C &1D) . 5mM of Cis and 1.25 mM of Enz in combination induced protein expression of BAX, Cleaved Caspase3, and Cleaved PARP in both cell lines. Bcl-2 protein expression was inhibited by EnzþCis. EnzþCis also increased DNA damage response regulators ATM, ATR, phos-Histone1 and phosphorylated checkpoint kinase-1 (CHK1). Invasive and migratory potential of TCCSUP and J82 cells were reduced with EnzþCis treatment, and associated with downregulation of mesenchymal markers.
CONCLUSIONS: A high percentage of the bladder tumors from male patients in our cohort expressed AR. Inhibition of AR with Enz in combination with Cis resulted in growth inhibition, induction of apoptosis and DNA damage response regulators and abrogation of invasive Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e813
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